| Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease LB Travis, DA Hill, GM Dores, M Gospodarowicz, FE Van Leeuwen, ... Jama 290 (4), 465-475, 2003 | 811 | 2003 |
| Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease LB Travis, M Gospodarowicz, RE Curtis, E Aileen Clarke, M Andersson, ... Journal of the National Cancer Institute 94 (3), 182-192, 2002 | 682 | 2002 |
| Mast cell infiltration correlates with poor prognosis in Hodgkin's lymphoma D Molin, A Edström, I Glimelius, B Glimelius, G Nilsson, C Sundström, ... British journal of haematology 119 (1), 122-124, 2002 | 249 | 2002 |
| The role of pregnancy, perinatal factors and hormones in maternal cancer risk: a review of the evidence R Troisi, T Bjørge, M Gissler, T Grotmol, CM Kitahara, SM Myrtveit Saether, ... Journal of internal medicine 283 (5), 430-445, 2018 | 143 | 2018 |
| The impact of comorbid disease history on all-cause and cancer-specific mortality in myeloid leukemia and myeloma–a Swedish population-based study M Mohammadi, Y Cao, I Glimelius, M Bottai, S Eloranta, KE Smedby BMC cancer 15, 1-12, 2015 | 90 | 2015 |
| High proportions of PD-1+ and PD-L1+ leukocytes in classical Hodgkin lymphoma microenvironment are associated with inferior outcome P Hollander, P Kamper, KE Smedby, G Enblad, M Ludvigsen, ... Blood advances 1 (18), 1427-1439, 2017 | 63 | 2017 |
| Novel treatment concepts in Hodgkin lymphoma I Glimelius, A Diepstra Journal of internal medicine 281 (3), 247-260, 2017 | 63 | 2017 |
| Angiogenesis and mast cells in Hodgkin lymphoma I Glimelius, A Edström, M Fischer, G Nilsson, C Sundström, D Molin, ... Leukemia 19 (12), 2360-2362, 2005 | 58 | 2005 |
| Long‐term survival in young and middle‐aged H odgkin lymphoma patients in S weden 1992–2009—trends in cure proportions by clinical characteristics I Glimelius, S Ekberg, M Jerkeman, ET Chang, M Björkholm, ... American journal of hematology 90 (12), 1128-1134, 2015 | 55 | 2015 |
| p53 is associated with high‐risk and pinpoints TP53 missense mutations in mantle cell lymphoma JM Rodrigues, M Hassan, C Freiburghaus, CW Eskelund, C Geisler, ... British journal of haematology 191 (5), 796-805, 2020 | 48 | 2020 |
| Impact of comorbidity on disease characteristics, treatment intent and outcome in diffuse large B‐cell lymphoma: a Swedish lymphoma register study T Wästerlid, M Mohammadi, KE Smedby, I Glimelius, M Jerkeman, ... Journal of internal medicine 285 (4), 455-468, 2019 | 48 | 2019 |
| Sick leave and disability pension in Hodgkin lymphoma survivors by stage, treatment, and follow-up time—a population-based comparative study I Glimelius, S Ekberg, J Linderoth, M Jerkeman, ET Chang, M Neovius, ... Journal of cancer survivorship 9, 599-609, 2015 | 46 | 2015 |
| Autoimmune and atopic disorders and risk of classical Hodgkin lymphoma P Hollander, K Rostgaard, KE Smedby, ET Chang, RM Amini, ... American journal of epidemiology 182 (7), 624-632, 2015 | 46 | 2015 |
| IL‐9 expression contributes to the cellular composition in Hodgkin lymphoma I Glimelius, A Edström, RM Amini, M Fischer, G Nilsson, C Sundström, ... European journal of haematology 76 (4), 278-283, 2006 | 46 | 2006 |
| Pregnancy and the risk of relapse in patients diagnosed with Hodgkin lymphoma CE Weibull, S Eloranta, KE Smedby, M Björkholm, SY Kristinsson, ... Journal of Clinical Oncology 34 (4), 337-344, 2016 | 43 | 2016 |
| Exposure to UV radiation and risk of Hodgkin lymphoma: a pooled analysis A Monnereau, SL Glaser, CW Schupp, K Ekström Smedby, S de Sanjosé, ... Blood, The Journal of the American Society of Hematology 122 (20), 3492-3499, 2013 | 42 | 2013 |
| Bulky disease is the most important prognostic factor in Hodgkin lymphoma stage IIB I Glimelius, D Molin, RM Amini, A Gustavsson, B Glimelius, G Enblad European journal of haematology 71 (5), 327-333, 2003 | 42 | 2003 |
| Surgical complications in postchemotherapy retroperitoneal lymph node dissection for nonseminoma germ cell tumour: a population-based study from the Swedish Norwegian … A Gerdtsson, U Håkansson, M Törnblom, G Jancke, HFS Negaard, ... European Urology Oncology 3 (3), 382-389, 2020 | 41 | 2020 |
| Trends in the prevalence, incidence and survival of non‐Hodgkin lymphoma subtypes during the 21st century–a Swedish lymphoma register study S Ekberg, K E. Smedby, I Glimelius, H Nilsson‐Ehle, C Goldkuhl, ... British journal of haematology 189 (6), 1083-1092, 2020 | 38 | 2020 |
| Cancer risk in individuals with major birth defects: large Nordic population based case-control study among children, adolescents, and adults DS Daltveit, K Klungsøyr, A Engeland, A Ekbom, M Gissler, I Glimelius, ... bmj 371, 2020 | 37 | 2020 |
Mats JerkemanProfessor of Oncology, Lund UniversityVerified email at med.lu.se